Carmel Diagnostics ^{For Profit}

Carmel Diagnostics is a company that provides solutions to improve the outcome of IVF by determining the profile of individual embryos using oxidative stress as a biomarker. Their product, Fertissimo, is the first benchtop system that enables non-invasive testing by sampling the culture medium while leaving embryos intact. Clinical data demonstrates an increase of up to 20% in IVF outcomes compared with the existing gold standard. The company has received grants from the European Union and Israel Innovation Authority. Contact info: not provided.